Pyrido[2,3-d]pyrimidines: Discovery and preliminary SAR of a novel series of DYRK1B and DYRK1A inhibitors-Reference-Cited by-同舟云学术

Pyrido[2,3-d]pyrimidines: Discovery and preliminary SAR of a novel series of DYRK1B and DYRK1A inhibitors

Published:2013-12 Issue:24 Volume:23 Page:6610-6615
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Anderson Kevin,Chen Yi,Chen Zhi,Dominique Romyr,Glenn Kelli,He Yang,Janson Cheryl,Luk Kin-Chun,Lukacs Christine,Polonskaia Ann,Qiao Qi,Railkar Aruna,Rossman Pamela,Sun Hongmao,Xiang Qing,Vilenchik Masha^ORCID,Wovkulich Peter,Zhang Xiaolei

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference18 articles.

1. The Kinase Mirk/dyrk1B: A Possible Therapeutic Target in Pancreatic Cancer

2. Mirk/dyrk1B Kinase in Ovarian Cancer

3. The Kinase Mirk/Dyrk1B Mediates Cell Survival in Pancreatic Ductal Adenocarcinoma

4. The Survival Kinase Mirk/Dyrk1B Is a Downstream Effector of Oncogenic K-ras in Pancreatic Cancer

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review on synthetic inhibitors of dual-specific tyrosine phosphorylation-regulated kinase 1A (DYRK1A) for the treatment of Alzheimer’s disease (AD);Bioorganic & Medicinal Chemistry;2024-09

2. Dual Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors: The Quest for a Disease-Modifying Treatment for Alzheimer’s Disease;Deciphering Drug Targets for Alzheimer’s Disease;2023

3. о-Aminopyrimidine Aldehydes and Ketones: Synthesis and use as Precursors to Fused Pyrimidines;Chemistry of Heterocyclic Compounds;2022-11

4. Design and biological evaluation of substituted 5,7-dihydro-6H-indolo[2,3-c]quinolin-6-one as novel selective Haspin inhibitors;Journal of Enzyme Inhibition and Medicinal Chemistry;2022-06-07

5. QSAR modeling, molecular docking, ADMET prediction and molecular dynamics simulations of some 6-arylquinazolin-4-amine derivatives as DYRK1A inhibitors;Journal of Molecular Structure;2022-06